Mesoblast Acquires Exclusive Global License for CAR Technology Platform
Mesoblast has acquired an exclusive worldwide license to a patented chimeric antigen receptor technology platform to enhance mesenchymal lineage stromal cell products for…
Mesoblast has acquired an exclusive worldwide license to a patented chimeric antigen receptor technology platform to enhance mesenchymal lineage stromal cell products for…
DXA scans use low-dose X-rays to evaluate bone mineral density and estimate body composition. According to medical experts, the imaging tests are recommended for women aged … Read more